Abstract
Background and objective Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a chronic respiratory infection with increasing prevalence and mortality worldwide. Chronic pulmonary aspergillosis (CPA) is a significant complication of NTM-PD and is associated with a poor prognosis. In this multicenter, retrospective, cohort study, we examined the epidemiology, comorbidities, risk factors for CPA coinfection, and long-term prognoses of patients with NTM-PD infected with CPA in Japan.
Methods Patients aged ≥ 8 years with newly diagnosed NTM-PD who visited 18 acute-care hospitals in Kyushu, Japan, between 2010 and 2017 were included. Medical records were reviewed for patient characteristics, underlying diseases, mycobacterial species, laboratory data, radiological features, Aspergillus coinfection, and all-cause mortality. Risk factors for CPA coinfection were analyzed using multiple logistic regression, and survival analysis was performed before and after propensity score matching with risk factors.
Results Among 1,304 patients with NTM-PD, 45 (3.5%) were diagnosed with CPA during the observation period. Risk factors for CPA coinfection included male sex, chronic obstructive pulmonary disease, oral corticosteroid use, and cavity formation. All-cause mortality was significantly higher in patients with NTM-PD with CPA than in those without CPA (log-rank test, P < .001; crude HR, 3.98). Survival analysis after propensity score matching confirmed that CPA was an independent poor prognostic factor (log-rank test, P = .036; adjusted HR, 1.59).
Conclusion CPA is an independent poor prognostic factor in patients with NTM-PD. Clinicians must consider CPA when treating patients with NTM-PD, particularly those with high-risk factors, to ensure their timely diagnosis and management.
Summary at a Glance A study of 1,304 NTM-PD patients in Japan found that 3.5% had chronic pulmonary aspergillosis (CPA), significantly increasing their mortality risk. Key risk factors for CPA included male sex, COPD, corticosteroid use, and cavity formation. CPA is an independent poor prognostic factor, highlighting the need for timely diagnosis and management.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partly conducted by Non-profit Organization Aimed to Support Community Medicine Research in Nagasaki (3612) and the joint research program of the Research Center for GLOBAL and LOCAL Infectious Diseases, Oita University (2023B15).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of Nagasaki University Hospital gave ethical approval for this work (approval number: 22121903)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Abbreviations
- CCPA
- chronic cavitary pulmonary aspergillosis
- CFPA
- chronic fibrosing pulmonary aspergillosis
- CPPA
- chronic progressive pulmonary aspergillosis
- CPA
- chronic pulmonary aspergillosis
- JSTNM
- Japanese Society for Tuberculosis and Nontuberculous Mycobacteriosis
- NB
- nodular bronchiectasis
- NTM-PD
- nontuberculous mycobacterial pulmonary disease
- SAIA
- subacute invasive pulmonary aspergillosis
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos